Worldwide Life Science Analytics Industry to 2029 – Increasing Acceptance of Analytics Solutions in Clinical Trials is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Life Science Analytics Market Analysis by Component, by Type, by Application, by Delivery, by End User by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The life science analytics market size is estimated to be USD 24.6 billion in 2021 and is expected to witness a CAGR of 15.31% during the forecast period 2022-2029.

Technological advancements, data storage in the life sciences industry, increasing acceptance of analytics solutions in clinical trials, rising adoption of analytics for sales and marketing applications, and demand for improved data standardisation are some of the major factors that boosts global market growth.

Also, rising incidence of chronic diseases, mounting pressure to reduce healthcare spending, and the need for improved patient outcomes are other factors that propelling the growth during the forecast period. However, high implementation cost hindering the market growth.

Companies Mentioned

  • Oracle Corporation (US)
  • Accenture (Ireland)
  • SAS Institute Inc. (US)
  • IBM Corporation (US)
  • IQVIA (US)
  • Wipro (India)
  • Cognizant (US)
  • SCIO Health Analytics (US)
  • Allscripts Healthcare Solutions (US)
  • Cerner Corporation (US)
  • Microsoft (US)
  • Infosys Limited (US)
  • MaxisIT (US)
  • Optum (US)
  • Cotiviti (US)

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including component, type, application, delivery, and end user from 2021 to 2029.

Segmentation: Life Science Analytics Market Report 2021-2029

By Component (Revenue, USD Billion)

By Type (Revenue, USD Billion)

  • Descriptive
  • Reporting
  • Prescriptive
  • Predictive

By Application (Revenue, USD Billion)

  • Sales & Marketing Support
  • Research & Development
  • Supply Chain Analytics
  • Pharmacovigilance
  • Regulatory Compliance

By Delivery (Revenue, USD Billion)

By End User (Revenue, USD Billion)

  • Biotechnology
  • Medical Device
  • Pharmaceutical
  • Others

By Region (Revenue, USD Billion)

North America

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

For more information about this report visit

Leave a Comment